Colchicine-induced myoneuropathy in a cyclosporine-treated renal transplant recipient
- PMID: 26877917
- PMCID: PMC4713917
- DOI: 10.1016/j.krcp.2013.04.003
Colchicine-induced myoneuropathy in a cyclosporine-treated renal transplant recipient
Abstract
Colchicine is a relatively safe medication that is widely used for both prevention and treatment of gout attack. However, serious adverse events, including myoneuropathy and multiorgan failure, have been reported. We report a case of colchicine-induced myoneuropathy in a female kidney transplant recipient who had been taking cyclosporine. She developed gastrointestinal discomfort and paresthesia 5 days after the initiation of colchicine. She showed signs of myoneuropathy, and hepatic and renal injury. Colchicine toxicity was suspected, and colchicine was discontinued. Her symptoms and laboratory findings improved gradually. Literature was reviewed for previous reports of colchicine-induced myoneuropathy in solid organ transplant recipients.
Keywords: Colchicine; Cyclosporine; Gout; Myoneuropathy; Renal transplant.
Similar articles
-
Colchicine myoneuropathy in a renal transplant patient.Transpl Int. 2002 Jul;15(7):374-6. doi: 10.1007/s00147-002-0426-9. Epub 2002 Jun 20. Transpl Int. 2002. PMID: 12122515
-
Acute onset of colchicine myoneuropathy in cardiac transplant recipients: case studies of three patients.Clin Neurol Neurosurg. 1997 Dec;99(4):266-70. doi: 10.1016/s0303-8467(97)00092-9. Clin Neurol Neurosurg. 1997. PMID: 9491303
-
Colchicine myoneuropathy in chronic renal failure patients with gout.Nephrology (Carlton). 2006 Apr;11(2):147-50. doi: 10.1111/j.1440-1797.2006.00542.x. Nephrology (Carlton). 2006. PMID: 16669978
-
Colchicine-Induced Myopathy in a Tacrolimus-Treated Renal Transplant Recipient: Case Report and Literature Review.Am J Ther. 2016 Mar-Apr;23(2):e614-6. doi: 10.1097/MJT.0000000000000044. Am J Ther. 2016. PMID: 24732905 Review.
-
Colchicine myotoxicity: case reports and literature review.Pharmacotherapy. 2004 Dec;24(12):1784-92. doi: 10.1592/phco.24.17.1784.52334. Pharmacotherapy. 2004. PMID: 15585444 Review.
Cited by
-
Colchicine-Induced Acute Myopathy: Case Study From Saudi Arabia.Cureus. 2021 Dec 9;13(12):e20290. doi: 10.7759/cureus.20290. eCollection 2021 Dec. Cureus. 2021. PMID: 35028201 Free PMC article.
-
Efficacy and safety of gout flare prophylaxis and therapy use in people with chronic kidney disease: a Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)-initiated literature review.Arthritis Res Ther. 2021 Apr 28;23(1):130. doi: 10.1186/s13075-021-02416-y. Arthritis Res Ther. 2021. PMID: 33910619 Free PMC article. Review.
-
Therapeutic effects and mechanisms of N-(9,10-anthraquinone-2-ylcarbonyl) xanthine oxidase inhibitors on hyperuricemia.Front Pharmacol. 2022 Sep 2;13:950699. doi: 10.3389/fphar.2022.950699. eCollection 2022. Front Pharmacol. 2022. PMID: 36120294 Free PMC article.
-
Safety and efficacy of colchicine in crystal-induced arthritis flare in 54 patients with severe chronic kidney disease.RMD Open. 2024 Jan 31;10(1):e003872. doi: 10.1136/rmdopen-2023-003872. RMD Open. 2024. PMID: 38296804 Free PMC article.
References
-
- Lin H.Y., Rocher L.L., McQuillan M.A., Schmaltz S., Palella T.D., Fox I.H. Cyclosporine-induced hyperuricemia and gout. N Engl J Med. 1989;321:287–292. - PubMed
-
- Kuncl R.W., Duncan G., Watson D., Alderson K., Rogawski M.A., Peper M. Colchicine myopathy and neuropathy. N Engl J Med. 1987;316:1562–1568. - PubMed
-
- Minetti E.E., Minetti L. Multiple organ failure in a kidney transplant patient receiving both colchicine and cyclosporine. J Nephrol. 2003;16:421–425. - PubMed
-
- Ducloux D., Schuller V., Bresson-Vautrin C., Chalopin J.M. Colchicine myopathy in renal transplant recipients on cyclosporin. Nephrol Dial Transplant. 1997;12:2389–2392. - PubMed
-
- Jagose J.T., Bailey R.R. Muscle weakness due to colchicine in a renal transplant recipient. N Z Med J. 1997;110:343. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources